Tag: fda

Oral Treatment Spinal

FDA Approves Oral Treatment for Spinal Condition

Oral Treatment could prove effective against spinal muscular atrophy The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) as an oral treatment for patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting…

coronavirus update for May 25

Coronavirus Update for May 25, 2020

Your coronavirus update for May 25; stay up to date with Elite. More than 5.4 million cases of coronavirus (COVID-19) have been diagnosed worldwide as of Monday evening, including more than 345,000 deaths. Healthcare officials in the United States have reported more than 1.6…

fda news

FDA Offers Statement on Protecting Public Interests

Postmarket drug safety surveillance practices under scrutiny In 2016, the 21st Century Cures Act (Cures Act) amended the Federal Food, Drug, and Cosmetic Act to eliminate the requirement for the Food and Drug Administration (FDA) to prepare a summary analysis of adverse drug reaction…

Each year more than 350,000 professionals advance their career with Elite Learning.